Dietary Supplements | FDA
FDA updated its dietary supplements page, reinforcing existing labeling, NDI, and GMP requirements. No new regulations, but increased enforcement focus.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 5, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Ongoing; no specific deadline but recommended within 90 days to mitigate enforcement risk.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA refreshed its dietary supplements landing page, emphasizing current requirements for labeling, NDI notifications, structure/function claims, GMPs, and mandatory product listing. No new rules, but signals heightened enforcement.
Who it affects
Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers
What you must do
Review and ensure compliance with existing FDA labeling and GMP regulations; verify NDI notifications for new ingredients; update Supplement Facts panels if needed.
Deadline
Ongoing; no specific deadline but recommended within 90 days to mitigate enforcement risk.
Source: https://www.fda.gov/food/dietary-supplements
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trial